Skip to search formSkip to main contentSkip to account menu

Repinotan

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
5-HT1A-receptor-agonist repinotan fails to counteract remifentanil-induced ventilatory depression in healthy volunteers - a double blind, randomized controlled trial: 9AP1-8
2006
2006
Evaluation of interethnic differences in repinotan pharmacokinetics by using population approach.
Repinotan is a selective full serotonin receptor agonist at the 5-HT1A subtype which has been studied in phase I and II studies… 
2005
2005
Pharmacokinetics of Escalating Doses of Intravenous Repinotan in Healthy Male Volunteers
AbstractObjective: To investigate the pharmacokinetics of intravenous (IV) repinotan, a potent selective full serotonin (5-HT1a… 
2004
2004
Specific monoclonal and polyclonal antibodies for repinotan and its ring-open form
The invention relates to monoclonal and polyclonal antibodies, the repinotan and its ring-open form specifically recognize, their… 
2001
2001
Repinotan (BAY × 3702): A 5HT1A Agonist in Traumatically Brain Injured Patients
Repinotan is a high-affinity, selective, full agonist of the 5HT1A-receptor subtype with neuroprotective properties. This paper… 
2001
2001
The selective 5-HT(1A) receptor agonist repinotan HCl attenuates histopathology and spatial learning deficits following traumatic brain injury in rats.
The selective 5-HT(1A) receptor agonist Repinotan HCl (BAY x3702) has been reported to attenuate cortical damage and improve… 
2001
2001
Repinotan (BAY x 3702): a 5HT1A agonist in traumatically brain injured patients.
Repinotan is a high-affinity, selective, full agonist of the 5HT1A-receptor subtype with neuroprotective properties. This paper… 
2001
2001
Repinotan analogue,its preparing method and use
The present invention relates to a kit comprising a containing Swiss or Swiss-frequency frequency Melanotan Melanotan… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)